NCT00574041View on ClinicalTrials.gov

How Side Effects of Avonex Are Affected by Gradually Increasing to Full Dose vs Starting at Full Dose

PHASE4TerminatedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions
Relapsing Remitting Multiple Sclerosis
Interventions
DRUG

Interferon beta-1a

injected, once a week

Trial Locations (1)

3144

Coordinating Research Site, Malvern

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY